In the News

Share
1667 News Items found
Q&A
Dr. Sergio Giralt
Improving Treatment for Recurrent Multiple Myeloma With Ide-Cel CAR T Therapy
In this Q&A, MSK hematologic oncologist Sergio Giralt, MD, talks about a phase 3 trial of ide-cel CAR T therapy for people with recurrent multiple myeloma and what it may mean for people with this hard-to-treat blood cancer.
woman getting vaccine from doctor
HPV Vaccine Age Limit: You Might Not Be Too Old — What You Should Know
Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer.
Tobias M. Hohl, MD, PhD
Tobias M. Hohl Elected a 2022 AAAS Fellow
Tobias M. Hohl, MD, PhD, Chief of the Infectious Diseases Service in the Department of Medicine, was elected a 2022 Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest scientific society and publisher of the Science journals. This title is one of the most distinguished honors within the scientific community and is designed to recognize leaders for their notable contributions to science.
Patient Mary Oehrlein at her Long Island home near MSK Commack, where a diagnostic biopsy test identified the best treatment for her pancreatic cancer
Start Your Cancer Treatment Fast With MSK's Rapid Diagnosis
The day before Thanksgiving, Mary Oehrlein got the earth-shattering news. She’d had some tests at her local hospital to see what was causing her stomach problems. When she got a message to check her patient portal for results, she was stunned to read the words “possible pancreatic cancer.” She went to tell Rich, her husband of 53 years, and they cried.
Dr. Selwyn Vickers seen outdoors with his wife, Janice, and their four children.
Black History Seen Through the Remarkable Family of Dr. Selwyn Vickers
Experience a remarkable portrait of Black history in America through the family story of Dr. Selwyn Vickers, the President and CEO of Memorial Sloan Kettering Cancer Center.
Feature
Robin Bankins
FDA Approves First Treatment for Patients With All Forms of Histiocytosis
Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults.
MSK multiple myeloma specialist Sham Mailankody
Off-the-Shelf CAR T Cell Therapy for Multiple Myeloma Shows Promise
A new type of CAR T cell therapy for multiple myeloma could shorten the time to treatment.
detail shot of a scientist pipetting in a lab
MSK Research Highlights, January 20, 2023
New research from MSK explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair; reports findings from a clinical trial for people with androgen receptor-positive salivary gland cancer; and aims to understand the impact of tumor mutational burden on patients with locally advanced non-small cell lung cancer.
Q&A
MSK hematological oncologist Lindsey Roeker
Meet Chronic Lymphocytic Leukemia Expert Lindsey Roeker
Meet hematologic oncologist Lindsey Roeker and learn why people who have been diagnosed with chronic lymphocytic leukemia should come to MSK.
Dr. John Chodera in his lab
Shooting for the Moon: How the Drive To Tackle COVID-19 Will Speed Up Cancer Drug Discovery
During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.
MSK nurse scientists Ann Marie Mazzella-Ebstein, Margaret Barton-Burke, and Kristen Fessele
MSK Nurse Scientists: Driven by Compassion — and Data
Like all researchers, nurse scientists design studies, accumulate data, and publish their findings. Their concentration in nursing means that they’re focused on patient needs, perspectives, and outcomes. Whereas a medical doctor might study how a drug is working, a nurse scientist may take a more holistic view of how a treatment affects a patient’s and their family’s quality of life.
three tobacco hornworm caterpillars held in a scientist's hand
Move Over, Mice: Caterpillars Could Replace Some Mammals in the Study of Human Disease
How scientists are working to develop nonmammalian alternatives that could reduce the number of rodents used in biomedical research.
Postdoctoral researcher Yanan Ma, PhD
Go Fish: Why MSK Researchers Use Zebrafish To Study a Cancer-Linked Inflammation Pathway
A study led by postdoctoral researcher Yanan Ma from the lab of cell biologist Philipp Niethammer shows why diversity also matters in model animal research.
Boris Mueller, MD, Director, Radiation Oncology at MSK Bergen is seen standing in a hallway.
Breast Cancer and Tattoo-Less Radiation at MSK
Learn how people with early stage breast cancer can receive radiation therapy without the need for tattoos at Memorial Sloan Kettering Cancer Center.
Attendees of the fifth annual MSK-CTONG Symposium
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Urge International Harmonization to Accelerate Cancer Drug Approvals at Annual Event
Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou, China and New York on December 2, 2022.
detail shot of laboratory slides
MSK Research Highlights, December 23, 2022
New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.
Two photos of Anthony and Arianna Robles
Advanced Colorectal Cancer Treatment Targets KRAS Gene With Drug Combo
MSK investigators led a recent trial that examined a new two-drug combination for patients with advanced colorectal cancer caused by a gene mutation called KRAS-G12C. Research in the lab is focused on how to make these targeted drugs even more effective.
Feature
x-ray of bladder with large tumor
Bladder Preservation in Muscle-Invasive Bladder Cancer Based on DDR Genetic Mutations
MSK researchers are investigating a new way that people with bladder cancer can avoid bladder removal.
In the Lab
Dmitriy Zamarin and Sohrab Shah
MSK Team Focuses on Resistance to Immunotherapy in Ovarian Cancer
A collaborative team from MSK has uncovered important new findings that explain why ovarian cancer does not respond to immunotherapy.
Person in white lab coat using a pipette with a tiny test tube.
Top Cancer Research Advances at MSK in 2022
Read about some of the biggest scientific discoveries made by MSK researchers in 2022.